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INTRODUCTION
As there are about 5-10% of all skin diseases amount to benign skin lesions and 
other cosmetically disabling conditions, amenable to laser therapy, it is decided to find 
out the effect of  CO2 laser in the treatment from the patient’s point of view regarding 
better look cosmetically and  psychologically.

AIM AND OBJECTIVES OF THE STUDY
1. To asses the effect of  CO2 Laser in benign skin conditions.
2. To observe the side-effects of CO2  Laser  while and after treatment.
3.
                                            REVIEW OF LITERATURE
Laser has become an essential tool for dermatologic surgeons. Conditions that until very 
recently could not be successfully treated with an acceptable risk-benefit ratio can now 
be easily treated in the office setting by using one of an ever-expanding array of lasers.
HISTORY: (1, 3)
The theoretical  concept  of laser  light  production was first  proposed by Albert 
Einstein in 19161. The first stimulated emission of radiation in the microwave portion of 
the electromagnetic spectrum, known as  MASER, for  Microwave Amplification by the 
Stimulated  Emission of  Radiation, was achieved by Townes and Gordon in 19541.The 
first functional laser (Light Amplification by Stimulated Emission of Radiation) system 
was Ruby laser developed by Maiman in 19601.The first laser to be used in humans was a 
Ruby laser studied by Leon Goldman for removing tattoos in early 1960s1.Subsequently 
Nd-YAG  laser  in  1961,the  Argon  laser  in  1962  and   the  Co2  laser  in  1964  were 
introduced. 
The argon laser was first used to treat vascular lesions during the mid 1970s 5 but was 
limited by the high risk of scarring .It was only in 1983  5, with the publication of the 
theory  of  Selective   Photothermolysis,  that  a  further  understanding  of  laser-tissue 
interactions was possible.
Laser Light Properties: (1, 4)
“Light  amplification  stimulated  emission  of  radiation”  describes  the 
mechanism by which a laser produces tremendously bright light and is made possible by 
quantum mechanics of matter. Atoms are composed of a nucleus with electrons orbiting 
around it .The electrons are usually in an orbit as close as possible to the  nucleus ,  which 
is in their Resting or Ground state. If the electron absorbs a photon of light ( Fig.1 ), it 
moves into a higher,  more energetic orbit  that matches the energy absorbed from the 
photon. This more energetic or excited electron is relatively unstable ,and the electron 
falls back down spontaneously to its resting state orbit while emitting a photon of light 
with  the  same  energy  that  it  had  originally  absorbed  ,thus  maintaining  energy 
conservation. This process represents spontaneous emission of radiation ( Fig.2 )and is 
seen in fluorescence and phosphofluorescence  phenomena.
Fig.1. Absorption.
Fig.2. Spontaneous emission.
Fig.3. Stimulated emission.
Stimulated emission of radiation ( Fig.3 ) occurs when a electron already in an 
excited state absorbs a photon of light and emits two photons of light while returning to 
the resting state orbit. The emitted photons match the absorbed photon in wavelength, 
phase and direction. The electron was originally raised to an excited state by pumping 
energy  into  the laser cavity. The energy for emission of two photons come from the 
difference in energy between the excited and resting state of the electron plus the energy 
of the photon  that the electron just absorbed. This maintains energy conservation while 
doubling the number of photons in the laser cavity. This process is repeated many times 
in the laser cavity to create a very bright laser beam. Normally the population of electrons 
is  such  that  most  of  the  electrons  reside  in  the  resting  state,  when  the  majority  of 
electrons  in  the  laser  cavity  are  raised  to  higher  orbits  by  absorbing  energy,  the 
population is said to be inverted. The process of stimulated emission doesn’t produce a 
very sufficient or even noticeable amplification unless a population inversion occurs.
 Stimulated emission of radiation is distinct from conventional light by following ways:
1) MONOCHROMATICITY:1
Monochromatic radiation is radiation of single wavelength. All of the light is of a 
single ,discrete wavelength or more precisely, the light is of a narrow wavelength band in 
a Gaussian distribution around the characteristic wavelength of the laser. The wavelength 
is determined solely by the laser medium.
2)COHERENCE: (1, 5)
Light  can be considered as a sine wave.  The laser is  temporally and spatially 
coherent. (i.e) The light waves are in phase both in time and space. The light waves are 
perfectly aligned in laser light so that each peak exactly matches both in time and space 
and each trough likewise matches up with every trough. The property is important for 
beam handling, shaping,focusing and coupling into optical fibres.
3)COLLIMATION ( Fig.4 ): (1, 4, 5)
It refers to the nondivergent  and energy conserving properties of light in which 
the waves are  parallel.  This  is  the direct  result  of  temporal  and spatial  coherence.  A 
collimated beam has the same spot size, no matter how far away or close to the skin one 
holds the laser handpiece. Most lasers use a focusing lens in the handpiece. This means 
that the spot size varies depending on how far away from or close to the skin one holds 
the handpiece.   
Fig.4. Collimated beam of light
THE PRACTICAL LASER ( Fig.5 ): 4
All Practical lasers can be divided into four major sections:
Fig.5. Schematic drawing of a generic laser system
1)LASING MEDIUM (Active medium ,Gain medium):
Lasing medium represents  the heart  of  the laser  system and lasers  are  named 
according  to  their  lasing  Medium.  It  supplies  the  electrons  needed  for  stimulated 
emission  of  radiation  and  determines  the  wavelength  of  the  radiation  produced.  The 
lasing medium can be gaseous [Argon, CO2, He-Ne, Copper Vapour, Copper Bromide, 
Excimer  or  Krypton]  ,   liquid  [  Tunable  dye,   Rhodamine],  solid  [Alexandrite, 
Erbium:yttrium-aluminium-garnet  (Er:YAG)  ,  Neodymium:yttrium-aluminium-garnet 
(Nd-YAG), Ruby or Diode] or free elcetrons.
2) OPTICAL RESONANCE CAVITY:
It encloses the laser medium and contains the amplification or excitation process. 
It may be manufactured of metal or ceramic and typically has mirrors at either end. They 
are aligned precisely so that their axis are parallel and are along the axis of the laser 
medium. One of the surfaces is 100% reflective but the other is only 90-95% reflective. 
These mirrors (plane or curved) serve to reflect the photons from the excited atoms back 
and forth many times between the opposite ends of the tube , resulting in amplification. It 
is through partially reflective surface that the laser energy emerges as the laser beam, 
which is referred to as output coupling. Thus it provides positive feedback amplification.
3) PUMPING SYSTEMS:
It  supplies  energy to  the  lasing  material  to  create  and  maintain  a  population 
inversion within it. The mechanism of energy transfer is chosen and tailored to suit the 
particular laser. Efficiency of pumping system is usually low,varying from a fraction of a 
percentage  in  most  systems   upto   30% in  a  few  cases.  Primarily  because  of  such 
inefficiency ,cooling systems and large supplies are necessary and are incorporated in 
many systems.
Common  pump  sources  include  optical  devices,   flashlamps,   other 
lasers(Argon,N2,Excimer,Xenon  fluoride)  and  electrical  discharges,  direct  current 
excitation and radiofrequency. Most optical pumping involves the use of a flashlamps. 
Electrical  pumping  is  probably  the  most  common  of  the  pumpings  used  in  medical 
systems.
4) LASER BEAM DELIVERY DEVICES:
Three  systems  are  currently  being  used  to  deliver  laser  light  from the  optical 
cavity to the tissue:
a) An articulated arm involves the use of rigid tubes with reflective mirrors at 
each connecting end.
b) Fibroptics are fibres consisting mainly of quartz and are used to transmit light.
c) Manual control of laser light delivery is subjective and can be inaccurate even 
in experience hands. Micromanipulator improves the accuracy of laser light delivery and
can  be  connected  to  the  fibre  optics  or  the  articulated  arm  through  a  microscope. 
Automatic  scanning devices involve the use of computer-controlled micromanipulator 
that deliver laser light in a controlled manner. Most lasers in current use use noncontact 
handpieces;  that  is,  only the laser beam itself  is  allowed to interact  directly with the 
tissue.  In  noncontact  systems,  the  handpiece  contains  only a  converging  lens  system 
( focusing the beam to one or more spot sizes at the operating distance) and a pointing 
guide which aids the surgeons in controlling the distance between the handpiece and the 
target tissue.
LASER PHYISCS (1, 3, 4, 6)
The interaction of laser energy with the tissue depends on a number of factors namely 
power, spot size, duration of exposure, wavelength and tissue properties.
1. Energy:
Light is measured in fundamental energy units called Joules.
2. Power:
It is the rate of energy delivery measured in Watts. 1Watts ==1joules/Sec
3. Fluence or Energy density:
It  is  the actual  amount of energy applied to the unit  area of target  tissue and 
depends the exposure time. It reflects the total energy delivered to the tissue which is 
directly related to the volume of tissue that will be treated.
Fluence (Joules/Cm2) == Power x Exposure time (Sec)/Area (Cm2)
As the energy fluence increases, tissue coagulation increases as well.
4. Irradiance or Power density:
It is rate of energy delivery (Power) per unit area to an object. Low irradiance 
results in coagulation. Higher irradiance results in tissue vaporization. It is independent of 
pulse duration. Therefore it is usually used when referring to continuous-wave lasers such 
as CO2 laser, since there is no fixed pulse duration.
Irradiance == Watts / Spot size (cm2)
5. Cross-Sectional Power density:
It is an average power over the cross-sectional area of the laser beam that is taken 
to be uniform. It is made up of tranverse electric modes (TEMs). TEM is the distribution 
of energy across the laser beam diameter. The types of TEM are TEMoo (the lowest 
order mode used , the energy distribution follows a Bell shape in which the peak power 
density is at the centre of the beam) and TEMo1 (Energy distribution has a Doughnut 
shape with a cold spot in the centre; this is less suitable for incisional work).
6. TEMPORAL MODES OF OUTPUT:
Laser  operate in either a pulsed, continuous or quasi-continuous mode.
PULSED MODE:
Pulsed lasers deliver their energy in a single discrete pulse or a train of pulses. 
Frequency refers to the number of pulses delivered in one second ,and pulse width or 
pulse duration is the length of the pulse in seconds. In general, a pulsed lasers produces 
more  intense  energy and less  adjacent  tissue  damage  than  continuous  lasers.  This  is 
because the tissue is allowed to cool in between pulses. It has been shown that if laser 
irradiatioin is repeated before the tissue completely cools,  the temperature elevation is 
additive. This inadvertent energy increases the likelihood that heat can extend beyond the 
target into the surrounding structures.
CONTINUOUS MODE:
It produces a steady emission with little fluctuation. In other words , this type of 
laser emits a beam as soon as the foot pedal is depressed and then continues to lase until 
the foot pedal is released.
QUASI-CONTINUOUS:
Quasi-continuous lasers emit true pulses, but their duration is in nanoseconds with 
rates as high as 15,000/s.This results in ”machine gun” type of pulse delivery, which is so 
rapid that the tissues responds as if it were a continuous wave.
SKIN OPTICS (1, 5, 6)
Skin optics constantly changing with changes in pigmentation , hydration , age , 
body site and genetic background. Light can interact with skin in the following ways 
( Fig.6 ).
1. REFLECTION: 6
About  5-7% of  incident  light  at  all  wavelengths  is  reflected from the stratum 
corneum air interface without any clinical effect.
2. ABSORPTION:
In the epidermis and stratum corneum, radiation wavelengths below 300 nm is 
absorbed rather than reflected. When electromagnetic radiation encounters skin, photons 
are absorbed by individual molecules, called chromophores.
CHROMOPHORES (1, 5) ABSORPTION WAVELENGTH
Protein,  Urocanic  acid,  Melanin, 
Nucleic  acid
UV C and B range (<320 nm)
Melanin 320—1,000 nm
Water >1,000 nm
Oxyhaemoglobin, Deoxyhaemoglobin UVA, Blue, Green, Yellow light
Collagen Visible and Near-infrared regions
Radiation with wavelengths greater than 300 nm have a greater degree of penetration  and 
can  therefore reach  the  dermis.  The  term “Optical  window” 5 refers  to  the  ability of 
radiation to penetrate deep into skin tissue because of low absorption and low scattering. 
This applies to radiation of wavelengths between 600—1,300 nm. Melanin is the  main 
 chromophore at this spectrum.
3. SCATTERING: (1, 5) 
It is largely due to collagen in the dermis.
Objects wavelength Scattering
Smaller than that of  light Rayleigh scattering (relatively weak)
Matcthing the incident light Forward-directed  (inversely  with  the 
wavelength)
Greater than that of light Highly  forwarded  –directed 
(independent
of wavelength)
4. TRANSMISSION:5
Residual light is transmitted to Subcutaneous tissue . This is largely dependent on 
wavelength.
Fig.6. Fate of incident light on skin.
LASER --- TISSUE INTERACTION
1. Photothermolytic effect: 3
  Photothermal  interactions,  are derived directly from heat generated by laser.
TEMPERATURE TISSUE DAMAGE
Below 50oC Reversible
50—100oC Irreversible
Above 100oC Vaporization
Extent of tissue damage is directly proportional to the amount of heat dissipated from the 
target site to the surrounding tissue. It depends upon the rate of heating determined by 
power density and exposure time.
2. Photomechanical effect:6
Here, High energy-level pulse laser disperses the target tissue by rapid thermal 
expansion and Local vaporization. Eg. Q-Switched ruby laser for removal of  tattoo.
3. Photoacoustic effect:3
The  high-energy  rapidly  pulsed  laser   mechanically  fragment  and  shatter  the 
pigmented  chromophore or particles. The smaller  fragments are cleared away by the 
body lymphatics , Vasculature  etc.
4. Photochemistry:3
This principle is utilized for photodynamic therapy. This involves the use of laser, 
in conjunction with a topical or systemic photosensitizer ,  in producing the beneficial 
effects.
5. Selective photothermolysis:1
To achieve selective photothermolysis,  the exposure to laser energy must be less 
than  or  equal  to  the  thermal  relaxation  time  of  the  target  chromophore.  Thermal 
relaxation  time7 is  the  time  needed for  an  object  to  dissipate  about  two-thirds  of  its 
absorbed heat. It is related to shape and size of target. For most chromophore in the skin, 
the thermal relaxation time is proportional to the square of the object’s diameter. Since 
large objects lose heat more slowly than small objects do, larger chromophores  will have 
longer thermal relaxation times.
Thermal relaxation time of laser targets:7
Diameter (µm) Thermal relaxation time
(tr)
EPIDERMIS 60 2  m sec
BASAL LAYER 20 400 µsec
MELANOSOME 1 0.2 µsec
MICROVESSELS 20
50
100
140 µsec
1.2 m sec
3.6 m sec
ERYTHROCYTES 5 5 µsec
HAIR BULGE >100 2 m sec
6. SKIN COOLING: (5, 6)
Skin cooling before, during and after a laser pulse helps to protect the epidermis 
and superficial dermis from thermal injury and to reduce pain and swelling. Cooling may 
take three forms.
a) Cold air convection:
Air, chilled to temperatures as low as -30oC, is directed onto the area to be treated.
b) Contact cooling:
This may involve simple application of ice-packs or sophisticated systems which 
pass chilled water between colorless and transparent plates which are usually sapphire as 
it is a far more efficient conductor than glass.
C) Cryogen spray (dynamic ) cooling:
A  frozen  gas  sprayed  onto  the  skin  immediately  below  the  laser  pulse. 
Evaporative cooling has a high heat transfer coefficient and this is therefore the most 
efficient way of   precooling.
TYPES OF LASERS (2, 8)
TYPE LASE
R
WAVEL
ENGTH 
(nm)
MODE 
OF 
EMISSI
ON
LASING 
MEDIUM
DEPTH 
OF 
PENET
RATIO
CHROMOPH
ORES
NVisible  
400-700
nm
Argon 
Dye
Ruby
Alex 
andrit
e
Krypto
n
Coppe
r
Nd-
YAG
488- 514
 
577-585 
(pulsed)
570-630 
(Tunable)
694
755
521,  530, 
568
511, 578
532
CW
Q-
switch
Q-
Switch
Q-
switch
CW
Pulsed
Q-
switch
Argon gas
Copper 
Rhodamine
-G
Ruby 
Crystal
Alexandrite 
crystals
Krypton 
Gas
Crystals
1-2 mm
1-2 mm
1mm
1.5mm
1.6mm
Hemoglobin, 
Melanin
Melanin, 
Tattoos,
Hemoglobin
Melanin, 
Tattoos
Tattoos  , 
Melanin
Hemoglobin, 
Melanin
Hemoglobin,
Melanin, 
Tattoos  (Red)
Near 
infrared
Diode 810 CW,Pul
sed
Crystals 4mm Melanin
Hemoglobin
Nd-
YAG
1064 CW, 
Q-
Switch
Crystals 5mm Melanin, 
Tattoos,
Hemoglobin
Mid 
infrared
Er-
YAG
2940 CW, 
Q-
Switch
Crystals 0.03mm 
per pass
Water
Far 
infrared
CO2 10,600 CW, SP 1part 
CO2,1.5 
parts  N2, 4 
parts 
Helium
0.1mm 
per pass
Water
LASERS FOR TREATING PIGMENTED LESIONS 8
LASER WAVELENGTH(nm) LOCATION  OF 
TARGETED 
PIGMENT
Flashlamp   pumped 
PDL
504, 510 Epidermis,  Superficial 
Dermis
QSNd-YAg 532 Epidermis, 
Superficial Dermis
QS Ruby (QSR) 694 Epidermis, Dermis
QS Alexandrite 755 Epidermis, Dermis
QS Nd-YAG 1064 Deep Dermis
Long-pulsed Ruby 694 Dermis (Larger targets)
Long pulsed Alexandrite 755 Dermis (Larger targets)
LESION LASER OF CHOICE
Café-au-lait Pulsed dye laser
Small congenital nevi
Nevus  spilus,   Nevus of  Ota or Ito,  
Tattoos
Long-pulsed ruby
Q-switched ruby laser
Lentigines QS Nd-YAG
Becker’s   nevus Long-pulsed ruby laser
LASERS FOR TREATING VASCULAR LESIONS (5, 6, 8, 9, 10)
ARGON LASER First  laser  used  for  the  treatment  of 
Portwine   Stain  and   remained  the 
treatment of choice until the late 1980s.
KRYPTON LASER Facial telangiectasia  and leg veins
COPPER VAPOUR LASER Portwine  stain
FLASHLAMP-PUMPED  PULSED 
DYE LASER (Treament of choice)
Portwine  stain,   hemangioma, 
Telangiectasia,  arborizing leg veins 
LASERS FOR HAIR REMOVAL 8
1. Nd-YAG laser
2. Long-pulsed ruby laser
3 Alexandrite laser
4. Diode laser
5. Intense xenon flashlamp
LASERS FOR TATTOO REMOVAL8
COLOR OF TATTOO OPTIMAL LASER ALTERNATIVE 
LASER
BLUE-BLACK Q-switched ruby Laser Q-switched alexandrite
QS Nd-YAG
GREEN Q-switched  alexandrite Q-switched  ruby, 
QS Nd-YAG
RED,  ORANGE, 
YELLOW
Pulsed dye laser QS Nd-YAG
COMPLICATIONS AND HAZARDS OF LASER:13
POSSIBLE COMPLICATIONS OF LASER THERAPY:
1) Immediate  Erythema,  oedema,  pain,  exudation,  purpura
2) Secondary infection
3) Pigmentary changes: Hyperpigmentation,  hypopigmentation
4) Textural changes, atrophy
5) Scarring,  keloid
POTENTIAL HAZARDS TO LASER MEDICINE:
1) Hazard to eye === Retina, especially macula: Permanent visual loss
[   Suitable protective eye goggles, eye-shields]
2) Hazard to skin === severe burns and  scarring
[Avoid by training and  experience]
3) Electrical hazard === High voltage: Life threatening
[  Strictly follow the safety precautions]
4) Hazards from Fumes and  vaporized tissues== Mutagenic and  carcinogenic
              Exacerbate asthma and  emphysema
Infectious risk ( Staph.aureus and neisseria ) 
                                                                                                       HPV,  HIV
                                        [Fume evacuator, good ventilation, mask]
PRECAUTIONS IN LASER THERAPY:13
1) ALWAYS wear safety goggles with recommended filters whenever the laser in use.
2) ALWAYS lock the door of the room during treatment.
3) NEVER look directly into the laser beam; or at scattered or reflected laser light.
4) NEVER point the laser handpiece at any person except at the treated area.
5) NEVER remove any covers from the cabinet of the machine and attempt to repair.
6) NEVER use the laser in the presenc of flammable anaesthetics.
7) NEVER   step on or abruptly bend the fibre-optic cable.
8) NEVER move the laser machine during operation or within 30 minutes of turning off.
9) DO NOT   turn off  the machine immediately after treatment.
10) DO NOT   turn off the main electrical switch.
BEFORE TREATMENT:13
i) Turn on the laser machine for warm up
ii) Written consent after explanation of the procedures
iii) Take Clinical Photographs
iv) Ensure  the patient having eye-protection
v) Prepare local anaesthetics if necessary
Lignocaine ( without  adrenaline)
vi) Lock the door and turn on the warning lamp.
DURING TREATMENT:13
i) Ensure that the patient has eye-protection all the time
ii) Measure the treatment time
iii) Plume suction if necessary
AFTER TREATMENT:13
i) Apply antiseptic cream or emollient for the patient
ii) In between treatment, keep the machine at standby.
iii) After treatment for all patients, wait for sometime before turn off the machine
AFTER CARE FOLLOWING LASER TREATMENT:13
i) Expect a  sunburn - like reaction with possible blistering within the first 24-48 hrs. 
Pain is usually minimal and can be relieved with either analgesics and / or cool  soaks 
with a wash cloth.
ii) A crust or scab may occur and  should  last for 7-14 days. Don’t pick off the scab.
iii) Keep the area clean and dry until the scab / crust falls off. Wash gently with Soap and 
water and apply a thin layer of moisturizer or antibiotic ointment.
iv) Once   the  scab  /  crust  has  come off  the  area  may look pink  and  even slightly 
depressed or indented. Both the pinkness and depression should improve over the next 
several weeks to months.
v)Avoid direct sunlight or sun exposure to the treated area for 3-6 months. Use at least an 
SPF of 15 or greater sunscreen, or wear a hat or other protective clothing. Be aware that 
unprotected sun exposure can result in an uneven  repigmentation, producing brown spots 
that can take months to fade away and in rare cases may be permanent.
vi)Be patient - It may take up to three months to adequately judge the true response of 
condition subjected to treatment. 
CARBON DIOXIDE LASER
               The CO2 laser was once called workhorse1 of lasers in dermatology.
EVOLUTION OF CO2 LASER IN DERMATOLOGY:
                      CO2 Laser was first developed  by Patel at Bell in 1964 11 and is used most 
frequently in modern dermatology. Ultrapulse CO2  and flashscan CO2 were used in 
1985. .The CO2 laser was first developed as a continuous beam surgical cutting tool. 
Focused to a spot size of 0.1 to 0.2 mm, this laser generates irradiances of 50 to 100,000 
w/cm2. Defocussed to a larger spot size and lower tissue energy density, the CO2 laser 
was used as an ablative tool to vaporize cutaneous lesions. Cutting with CO2 laser is 
relatively bloodless and has been thought by some to reduce the severity of postoperative 
pain by destroying sensory nerve endings. The use of the CW CO2 laser as a cutting 
instrument is limited by the unwanted damage to adjacent tissues.
Super pulsed lasers with higher peak power at a rapid pulse train of 250 to 1000 
Hz showed early promise, but after more detailed evaluation have not shown to produce 
more precise tissue cutting or a significant reduction in the zone of thermal injury. There 
has been a recent surge of interest in the use for skin resurfacing.
PROPERTIES OF CO2 LASER11
LASING MEDIUM           Mixture 1 part CO2:1.5 parts 
                                                                       Nitrogen:4 parts Helium gases
PUMP                                                                      Direct electric current
         Radiofrequency
EFFICIENCY          10-15 %
ELECTROMAGNETIC SPECTRUM                  Far Infrared, Invisible,    
                                      10,600nm                   
                                                                                                                            
DELIVERY         Mirrored articulating joints
ABSORPTION                                           Intracellular and  extra cellular 
water
DEPTH OF PENETRATION                             0.1 mm of soft tissue
EXTINCTION COEFFICIENT          0.1 mm of water
SCATTER IN TISSUE                                            Minimal
 
CO2 LASER OFFERS SEVERAL UNIQUE SURGICAL PROPERTIES 12
1) Disease volumes are vaporized under precise visual control
2) There need be little mechanical contact with the intended target.
3) Heat propagation to adjacent tissue is minimal.
4) Microorganisms at the impact site are automatically destroyed.
5) Vessels smaller than 0.5 mm in diameter (arterioles) are thermally sealed.
SIX PHYSICAL PRINCIPLES UNDERLYING SURGICAL EXPERTISE 12
I. Parameters concerned with minimizing thermal diffusion
1) Use rapid  super pulse or chopped wave, rather than  continuous wave ,thus preventing 
thermal relaxation between pulses.
2) Minimize duration of thermal  diffusion ,  by using high power settings.
3) Avoid  carbonization  of  the  impact  crater  ,  by  keeping  power  density  >750 
W/Cm2,wping away debris , performing ablations with the operating microscope, and not 
caramelizing extravasated blood.
II. Parameters  influencing  surgical control
4) Tailor  pulse fluence or average power density to individual hand-eye speed.
5) Control beam geometry by incremental focus-defocus of the microslad, using tightly 
focused spots for incision and  rounded beams for ablation.
6) Maintain high power in delicate situations, using shuttered pulses to maintain surgical 
control.
The  incident  beam of  the  CO2 laser  arises  from an  activated  medium 
containing CO2, N2 & Helium in the respective ratio of 1:1.5:411.It has a characteristic 
wavelength of 10,600nm and falls into the far infrared region.  97%11 of its energy is 
absorbed at its impact site in skin, and 98%11 is absorbed in water at a depth of 0.1- 
0.2.mm.Thus even the 3% of energy reflected in skin is absorbed totally after passing 
through a very short distance in adjacent tissue, the majority of which is water. The end 
result is a relatively small amount of thermal damage to tissue not in direct contact with 
the CO2 beam. In skin, the thermal damage extends for only 30-50µ from the impact site. 
The impact site on the other hand, receives virtually the total power output of the CO2 
laser, resulting in the instantaneous transformation of tissue water to steam and  thus, 
Vaporization or Evaporation.
The Clinical effect11 depends upon power, area of impact site and  time of 
Exposure.  Increase the power and  time of  exposure result  in  an increase in thermal 
damage. Basically,  the almost parallel beam arising from the plasma tube is delivered to 
an articulating hand piece through a system of perfectly aligned mirrors. Before exciting 
the hand piece,  the beam must pass through a lens, which causes the beam to be focused 
at a distance from the lens equal to its focal length. At this point, the beam is its smallest 
and   power  density  is  most  concentrated.  In  this  focused  mode  it  can  be  used  for 
excision.11 By increasing the target to hand piece distance, the beam becomes defocused. 
In this mode, it can be used for tissue Vaporization.11
CLINICAL APPLICATIONS OF THE CARBON DIOXIDE LASER
I. VAPORIZATION MODE (DEFOCUSED)11
TUMOROUS CONDITIONS
Angiofibroma
Syringoma
Trichoepithelioma
Neurofibroma
Actinic cheilitis
Superficial basal cell  carcinoma
VASCULAR CONDITIONS
Lymphangioma circumscriptum
Angiokeratoma
Port wine stain
Cherry angioma
Pyogenic granuloma
PROLIFERATIVE DISORDERS
Epidermal nevus
Xanthelasma
Verruca
Steatocystoma
Digital mucous cyst
Nodular amyloidosis
MISCELLANEOUS CONDITIONS
Decorative tattoo
Traumatic tattoo
Balanitis  xerotica  obliterans
Granuloma  faciale
Revision of grafts or flaps
II. EXCISIONAL MODE  ( FOCUSED)11
Rhinophyma
Keloid
Refractory  localised  type
Acne keloidalis nuchae
Earlobe
Bloodless surgery
Highly  vascular  tissue
Patients on  anticoagulant therapy
Treatment of cutaneous  malignancies
Mohs’ surgery
Excision of  stromal  independent  neoplasms
Squamous  cell carcinoma
Melanoma
Perforation of exposed cranial bone
Patients with  pacemakers  that restrict  electrosurgical  instrumentation.
CO2 LASER IS POTENTIALLY THE  TREATMENT  OF CHOICE13
Epidermal  nevus
Cutaneous  resurfacing  procedures
Actinic  cheilitis
Bowenoid  papulosis
Rhinophyma
Sublingual  keratosis
CO2 LASER MAY OFFER BETTER RESULTS OR FACILITATE THE   
PROCEDURE13
TUMOURS:
Angiofibroma
Syringoma
Trichoepithelioma
Neurofibroma
Seborrheic keratosis
Xanthelasma
Superficial basal cell carcinoma
Squamous cell carcinoma in- situ 
INFECTIONS:
Extensive or large condyloma acuminatum
Verruca vulgaris 
Recalcitrant wart
Cuaneous infection such as leishmaniasis
Debridement of  burns or infected ulcer
VASCULAR:
Lymphangioma  circumsriptum
Angiokeratoma
Pyogenic  granuloma
Cherry  angioma
Granuloma  faciale
OTHERS:
Cosmetic excisional surgery
Ingrowing toe nails
Lichen  planus of the penis
Hailey-Hailey disease
Chondrodermatitis  nodularis  helica  chronicus
Oral florid papillomatosis
Blepharoplasty
Hair transplant
LESIONS  THAT  BETTER  RESULTS  CAN  NOW  ACHIEVED  USING  NEW 
LASERS13
Café-au-lait spots
Ephelides
Lentigines
Port wine stain
Tattoo
Telangiectasia
PRE OPERATIVE CONSIDERATIONS 2
PLANNING:
Determine the type of  procedure (  Ablative Vs  Incisional)
Select the appropriate anesthesia (And Sedation , if necessary)
Make the patient  aware of what  to  expect postoperatively (Pain,  restriction of 
activities and wound care)
Ensure all equipment is in proper working  conditions
Make postoperative dressing material is at hand
SAFETY:
Ensure the safety of the patient, surgical staff and any observers, with laser both in 
and out of hand.
Laser safety equipments
Proper smoke evacuation equipment
Laser -approved surgical masks
Protective eyewear for all
Accessible water supply and  wet drapping.
SETTING:
Appropriate  settings  vary  from  surgeon  to  surgeon.  Changes  in  power  being 
delivered to a target can be adjusted by actually adjusting the laser output or by changing 
the impact spot size.
SPOT SIZE:
Hand  pieces  are  available  that  allow  for  delivery  of  a  variety  of  spot  sizes. 
Perhaps the most common are those that allow for delivery of impact spots of 1.0mm and 
2.0mm.Understand  that  the  impact  spot  printed  on  the  handpiece  is  only  for  that 
handpiece and only when it is held at the focal distance that is appropriate for the lens in 
that handoiece. This is usually accomplished safely, accurately and successfully with the 
use  of  stylus  of  appropriate  length  that  can  be  fitted  to  the  end  of  the  bore  of  the 
handpiece.  The  beam  exciting  from  a  CO2  laser  is  not  parallel  but  divergent,  and 
withdrawing the hand piece from the appropriate focal distance increases the size of the 
impact spot. (Moving the hand  piece closer than the focal length has a similar effect, as 
well  as  the  added  effect  of  overshoot).  Although  this  can  be  very effective  way of 
performing ablative procedures, it does require skill  and experience and is best learned 
under the watchful eye of a preceptor. On the other hand , incisional  procedures are less 
forgiving and require the hand piece to be held at the appropriate distance for reasonable, 
safe, and chare-free cutting. Hand pieces are available with cutting spot sizes of 0.1mm. 
The most common incisional hand pieces , however, have 0.2mm spot sizes. Although it 
may seem a minor  difference,  consider  that  the power required to  cut  with a 0.2mm 
impact spot in the same manner as with a 0.1mm spot is higher by a factor of  four than 
with the 0.1mm spot.
TECHNIQUE:2
INCISION:
Appropriate prepare, drape and anesthetize the patient. Draw the intended incision 
or excision with a surgical marking pen. Make sure the laser is set appropriately. Drape 
the  immediate  surgical  fields  with  wet  sterile  sponges  or  towels.  Bring  the  smoke 
evacuation system to the field prepared to remove vapour during procedure. Reasonable 
starting parameters should be 5 to 10W for a 0.1mm  spot or 10 to 20W for 0.2mm  spot.
Use a stylus to gauge the appropriate distance at which the hand pieces should be held 
from the target. Make an incision along the tongue depressor as a final check of  power, 
spot,  distance,  alignment of aiming and working beams, and hand stability.  Then the 
aiming beam  should be on or slightly inside the proposed incision line. Begin with a 
brief impact and check the effect .If  all settings and angles are appropriate, begin with 
incisional  pass.
After the first pass, asses the wound. If the incisional pass is of acceptable depth, 
it would be appropriate to increase the power output to the laser for maximum efficiency. 
Continue the next pass, and keep blood or melted fat from the field. If the areas  shows 
bleeding,  apply pressure  with  gauze  sponges  slowly,  but  with  continued   downward 
pressure. Immediately withdraw the hand piece several inches from the site, and with 
aiming  beam  pinpointing  the  target,  vaporize  to  achieve  haemostasis.  Complete  the 
excision by pulling the specimen up and away firmly yet gently while cutting at the base 
of the tissue.
ABLATION:
It  depends  on  experience  and  kill  as  well  as  the  type  of  ablative  procedure 
performed. With the laser set at a power of 10W and with an impact spot of 3—4mm, 
begin with a short impact in the centre of the lesion. Repeat this with a continuous burst 
and move to the peripheral margin of the lesion. Stop when the surface has been totally 
treated.  With  a   gauze  soaked  with  hydrogen  peroxide,  clean  off  the  resulting  char. 
Repeat the vaporize—cleanse cycle until the bleeding is stable and the wound created 
appears reasonably uniform.
POST OPERATIVE INSTRUCTIONS 13
i) Expect a  sunburn- like reaction with possible blistering within the first  24-48 hrs. 
Pain is usually minimal and can be relieved with either analgesics and / or cool  soaks 
with a wash cloth.
ii) A crust or scab may occur and  should  last for 7-14 days. Don’t pick off the scab.
iii) Keep the area clean and dry until the scab / crust falls off. Wash gently with soap and 
water and apply a thin layer of moisturizer or antibiotic ointment.
iv) Once the scab / crust has come off the area may look pink and even slightly depressed 
or  indented.  Both  the  pinkness  and depression  should  improve  over  the  next  several 
weeks to months.
v) Avoid direct sunlight or sun exposure to the treated area for 3-6 months. Use at least 
an SPF of 15 or greater sunscreen, or wear a hat or other protective clothing. Be aware 
that unprotected sun exposure can result in an uneven  repigmentation, producing brown 
spots that can take months to fade away and in rare cases may be permanent.
vi)Be patient === It may take up to three months to adequately judge the true response of 
condition subjected to treatment. 
                                                           MATERIALS
A    prospective  analytical  study  was  conducted  in  the  department  of  dermatology, 
government  stanley medical  college  and hospital,  chennai,  tamilnadu for  a  period  of 
twenty five months from august 2004 to september 2006.
Sixty cases were serially selected from the OPD who fulfill the inclusion 
criteria. This includes approximately 20% of failure expected either in the response to 
treatment and follow up. Selected cases were included after fulfilling the criteria, serially 
numbered, written consent obtained,  proforma filled and filed. They were subjected to 
laser treatment,  the mode, the power,  the frequency and the time of laser application 
calculated depending on the type and depth of lesion, site of involvement and patient’s 
skin  type.  All  the  patients  were  treated  under  local  anaesthesia  (  2%  Xylocaine). 
Immediate side-effects were noted if any and the patients were followed up 1st week, 2nd 
week, 1st month, 2nd month, 6th month and 12th month. During the post treatment period 
the patients were treated with topical antibiotics ( 1% Silver Sulphadiazine cream) and 
topical sunscreen like Zinc oxide cream. Procedures were repeated at variable intervals 
depending upon the response and the results were  analysed accordingly.
INCLUSION CRITERIA:
1.Uncomplicated   benign  skin  and  vascular  conditions  [Epidermal  nevus, 
Intradermal  naevus,  Naevus  sebaceous  of   jadassohn,  Lentigines,  Lymphangioma 
circumscriptum  ,Angiokeratoma,  Benign  appendageal  tumors,  Angiofibroma, 
Xanthelasma, etc].
2. Tattoo
3. Hypertrophic scar
4. Patients who gave written consent for clinical photos and treatment
EXCLUSION CRITERIA:
1. Patients who were not willing to give written consent.
2. Secondary infections of the lesion to be treated.
CONDITIONS  INCLUDED IN  OUR  STUDY:
ANGIOFIBROMA: (14, 15, 16, 17).
Facial angiofibroma are one of the major cutaneous manifestations of tuberous sclerosis 
complex   occurring  in  about  90% of  these  patients  resulting  in  significant  cosmetic 
disfigurement leading to emotional distress. The lesions can be  subjected  to CO2 laser 
with cosmetically acceptable results. We tried CO2 laser in five patients. 
INTRADERMAL  NEVUS:18
It  is an Acquired common melanocytic nevi characterized clinically by raised ,  dome 
shaped non-pigmented, sometimes pigmented nodules, mosty commonly seen on the face 
with often some overlying  telangiectatic vessels and outgrowth of one or two coarse 
terminal hair over the surface.The lesions can be treated with CO2 laser. We tried CO2 
laser in three patients.
NEVUS SEBACEOUS OF JADASSOHN:(19, 20).
Sebaceous nevi also known as organoid nevi are epidermal hamartomas predominantly of 
sebaceous  glands  characterized  clinically  by  sharply  circumscribed  yellow-orange, 
verrucous plaques varying from a few mm to several cm occuring most commonly over 
head  and  neck  area.  It  is  difficult  to  treat  and  often  the  therapeutic  outcome  is 
unsatisfactory or cosmetically unacceptable.CO2 laser is very versatile laser which has 
been successfully used to treat lesions which were considered untreatable. We tried CO2 
laser in two patients. 
VERRUCOUS EPIDERMAL NEVUS: (19, 21, 22, 23, 24, 25, 26).
They  are  congenital  non-inflammatory  cutaneous   hamartomas  composed  of 
keratinocytes characterized clinically by slightly pigmented velvety or warty streaks or 
plaques present since birth. With age, they darken and the surface becomes more warty. It 
is difficult to treat and often the therapeutic outcome is unsatisfactory. Co2 laser has been 
used successfully in treating  epidermal Nevus.
We tried CO2 laser in 14 patients. 
TATTOO REMOVAL:(27, 28).
Tattooing is the introduction of insoluble pigments into the skin to produce permanent 
pigment inscriptions and figures. Pigment is applied to the skin and then needles pierce 
the skin to force the material into the cutis. The pigment inserted may be carmine, indigo, 
India  ink,  chrome  green,  zinc  oxide,  cinnabar,  cobalt  blue,  cadmium  sulfide  etc. 
Treatment for the removal of tattoo marks is usually unsatisfactory. Various modalities of 
treatment  has  been  tried.  Regarding  lasers,  Q-Switched  Nd-YAG.  Q-Switched 
Alexandrite, Q-Switched Ruby, Pulsed Dye laser and CO2 laser are all useful. We tried 
CO2 laser in two patients.
NAEVUS OF OTA:29
It  was  first  described  by  Ota  in  1939.  It  is  also  known  as  nevus  fuscocaeruleus 
ophthalmomaxillaris. It is a dermal melanocytic hamartoma  characterized by unilateral 
bluish  brown  macular  discolorisation  involving  periorbital  region,  temple,  forehead, 
malar area, and nose. There is frequently also a patchy blue discolorisation of the sclera 
of the  ipsilateral eye and occasionally also of the conjunctiva,  cornea, and retina. The 
laser of choice in this condition is Q-Switched Ruby Laser( QSRL). So far combination 
of Co2 laser and Q-Swithched Ruby laser was tried in this condition. We tried CO2 laser 
in one patient.
LENTIGINES: (30, 31).
It is an uncommon syndrome probably determined by an  autosomal dominant gene. It 
usually starts in the first year of life with the development of multiple brown or black 
macules  distributed  in  a  horizontal  band  across  the  centre  of  the  face.  The  mucous 
membranes are not involved. They usually increased in the first decade of life. It may be 
associated with neurological features. It can be treated with CO2 laser, Argon laser,Q-
Switched Nd-YAG and Ruby laser and cryotherapy etc.  We tried CO2 laser in three 
patients.
 LYMPHANGIOMA CIRCUMSCRIPTUM: (32, 33, 34, 35).
It is a malformation of lymphatic channels due to localized sequestration of embryonic 
mesenchymal  masses  clinically  characterized  by  groups  of  deep-seated  vesiclelike 
papules which is usually yellowish, but may be pink, red, or dark. They usually present at 
birth or shortly afterwards. They become more profuse during childhood and may persist 
indefinitely. So far CO2 laser has been used  Successfully. We tried CO2 laser in two 
patients.
ANGIOKERATOMA OF FORDYCE:32
Known also an angioma of  the Scrotum and Vulva.  It  is  characterized clinically by 
multiple vascular papules 2 – 4 mm in diameter involving the scrotum or vulva affecting 
middle aged or elderly persons. So far CO2 laser has been used  Successfully. We tried 
CO2 laser in one patient.
MULTIPLE TRICHOEPITHELIOMA: (36, 37, 38).
It  is  a  benign  tumor  with  differentiation  toward  hair  structures.  It  is  also  known as 
epithelioma adenoides cysticum and multiple benign cystic epithelioma. The inheritance 
is autosomal dominant and the lesions first appear in childhood and gradually increase in 
number. It is characterized clinically by numerous rounded, skin colored, firm, papules 
and nodules 2-8 mm in diameter mainly involving the nasolabial folds and also on the 
nose,  forehead,  and  upper  lip.  Various  therapeutic  modalities  like  surgical  excision, 
dermabrasion, electrocautery, CO2 laser etc were being  tried. We tried CO2 laser in one 
patient.
SYRINGOMA: (18, 39, 40, 41).
It  represents  an  adenoma  of  intraepidermal  eccrine  sweat  duct  affecting  females 
predominantly at puberty. It is characterized clinically by multiple, small, skin-colored or 
slightly yellow, soft papules usually only 1 or 2 mm in diameter with common sites being 
the eyelids and upper cheeks. It can be treated with electrodessication and cryotherapy 
with liquid nitrogen. It can also be successfully treated with high energy pulsed CO2 
laser. We tried CO2 laser in six patients.
COLLOID MILIUM:42
It is a degenerative change secondary to chronic sun exposure charactertised clinically by 
the development of skin colored or slightly yellow 1 – 3mm papules appear in the sun 
exposed  areas  of  the  hands,  face,  neck  mand  ears  in  the  middle  –  aged  adults. 
Improvement has been reported following dermabrasion, destruction of the lesions with 
diathermy or  with  cryotherapy has  also  been  advocated,  but  the  cosmetic  results  are 
seldom satisfactory. But Co2 laser would give excellent cosmetic results. We tried CO2 
laser in one patient.
XANTHELASMA  PALPEBRARUM: (43, 44, 45, 46, 47).
It  is  the most  common type  of  xanthoma.  It  can be managed with surgical  excision, 
trichloroacetic acid cauterization and fulguration. Surgical excision is the most widely 
used form of  treatment.  However,  simple closure  after  excision  of  large lesions  may 
restrict eyelid closure. The CO2 laser photovaporization method used for this purpose is 
simple and avoid the eyelid closure problems. We tried CO2 laser in one patient.
HYPERTROPHIC  SCAR: (48, 49).
It represents an excessive connective tissue response to injury, which may be trivial. It 
can be managed with simple excision, silicone gel with adhesive tape, pressue alone or 
with occlusion, liquid nitrogen freezing and intralesional steroids. Hypertrophic scar can 
be resurfaced with Co2 laser. They are of limited efficacy and may even exacerbate the 
scarring process. We tried CO2 laser in one patient.
KELOID: (18,50, 51, 52, 53, 54).
It represents an excessive connective tissue response to injury, which may be trivial. It 
can be managed with simple excision, silicone gel with adhesive tape, pressue alone or 
with occlusion, liquid nitrogen freezing and intralesional steroids. Hypertrophic scar can 
be resurfaced with Co2 laser. They are of limited efficacy and may even exacerbate the 
scarring process. We tried CO2 laser in five patients.
ACNE   KELOIDALIS  NUCHAE:55
It is a chronic papular or pustular eruption localized to the nape of the neck and occipital 
area eventuating in keloid formation. It can be excised and vaporized successfully with 
CO2 laser. Although suggested in some reports, no clear advantage over other treatment 
modalities has been established. We tried CO2 laser in one patient.
ACTINIC CHEILITIS: (56, 57, 58, 59, 60, 61).
Actinic cheilitis, a precancerous condition, more commonly affects lower lip and occurs 
predominantly in men and in fair-skinned persons with other signs of actinic damage. It 
can progress to invasive squamous cell carcinoma that may metastasize in up to 13% of 
cases. Several treatments have been advocated for actinic cheilitis, including cryosurgery, 
topical 5-fluorouracil, and vermilionectomy. Carbon dioxide laser vaporization has also 
been reported to be effective and well tolerated. We tried CO2 laser in one patient.
METHODS
ANGIOFIBROMA
SEX / AGE SITE SETTINGS INTERVALS
3 Female 
patients;
15- 17yrs of 
age 
Face Power:4W
Mode: CW
Spot Size: 2mm
No. of Sittings: 
10
At an interval of 1-2  Months
2 Male 
Patients
20-30 yrs of 
age
Paranasal 
Area
Power:1W
Mode: SP
Spot Size: 
0.2mm
No. of sittings: 
One
At an interval of one month
INTRADERMAL NEVUS
SEX / AGE SITE SETTINGS INTERVAL
1st Patient
26 / Female
Right Cheek Power:4W
Mode: CW
Spot size:2mm
No. of settings: 2
At an Interval of 1 
Month
 2nd Patient Pre auricular 
area
Power:4W
Mode: CW
Spot size:2mm
No. of settings:1
Single Sitting
3rd  Patient Tip of the Nose Power:4W
Mode: CW
Spot size:2mm
No of settings:1
Single Sitting
NEVUS SEBACEOUS OF JADASSOHN
AGE /  
SEX
SITE SETTINGS INTERVALS
1st Patient
25 Yrs / 
Male
Lt. Cheek Power:4W
Mode: CW
Spot Size: 2mm
No. of Sittings:3
II Sitting: One Month later
III Sitting: 2 Weeks After 2nd 
2nd Patient
19Yrs / Fch
Vertex Power:1W
Mode: SP
Spot Size: 
0.2mm
No. Of Sittings:1
Single Sitting
VERRUCOUS EPIDERMAL NEVUS
AGE / SEX SITE SETTINGS INTERVALS
7 patients 
5-20yrs of 
age 
[4 females,
3 males]
Face, Nape 
of the Neck, 
Abdomen
Power:     4-5W
Mode: CW
Spot Size:2mm
No. of Sittings:2-4
At an Interval of about 14 
Days to One Month 
7 Patients
5-20yrs of 
age
[6 males, 1 
female]
Face, Chest, 
Abdomen
Power:    1-2W
Mode: SP
Spot Size:0.2mm
Sittings:2-4
At an Interval of about 14 
Days to One Month
TATTOO REMOVAL
AGE / SEX
SITE SETTINGS INTERVALS
23yr/ Male Rt. Side of 
Chest
Power:4 Watts
Mode: CW
Spot Size:2mm
Sitting: One
Single Sitting
AGE /  
SEX
SITE SETTINGS INTERVALS
26 Yrs / 
Male
Lt. Side of 
Chest
Power:8 Watts
Mode: CW
Spot Size:2mm
Sittings:3
At an Interval of One 
Month
NAEVUS OF OTA
.AGE /  SITE SETTINGS INTERVALS
SEX
28 Yrs / Male Lt. Malar Area Power: 1
Mode: SP
Spot 
Size:0.2mm
Sitting: Single
Single Sitting
LENTIGINES
.AGE 
/ SEX
SITE SETTINGS INTERVALS
21 Yrs / 
Female
FACE Power:1-2W
Mode: CW
Spot Size:1mm
Sittings:20
At an Interval of about 3 
– 4 Weeks
28 Yr / Male Rt.Temple
FACE
Power:2W
Mode: CW
Spot Size: 1mm
Sittings:4
Power: 1W
Mode: CW
Spot Size:1mm
Sittings:4
At an Interval of about 3 
– 4 Weeks
At an Interval of about 3 
– 4Weeks
25 Yrs / Male FACE Power:0.5W
Mode: SP
Spot Size:0.2mm
Sittings: One
LYMPHANGIOMA CIRCUMSCRIPTUM
AGE / SEX SITE SETTINGS INTERVALS
23 yrs / FM Rt. Side of 
Abdomen
Power:8W
Mode: SP
Spot 
Size:0.2mm
Sittings:3
At an interval of about 3—6 
Months
14 yrs / FM Lt. Side of 
chest
Power: 4W
Mode: CW
Size: 2mm
Sittings: Two
At an interval of about 2 
weeks.
ANGIOKERATOMA OF FORDYCE
.AGE /  
SEX
SITE SETTINGS INTERVALS
46 Yrs / Male Root of the 
Penis
Scrotum
For Both Sites
Power:1W
Mode: SP
Spot Size:0.2mm
Sittings: Single
Single Sitting
MULTIPLE TRICHOEPITHELIOMA
AGE / SEX
SITE SETTINGS INTERVALS
30 Yrs / 
Male
Nose Power:2watts
Mode: SP
Spot 
Size:0.2mm
Sittings:4 
At an Interval of About 1—
2Weeks at Various Sites
Treated Site at an interval of 2 
Weeks
SYRINGOMA
AGE /  
SEX
SITE SETTINGS INTERVALS
6 female 
patients,
20 - 30 
years
Upper eyelid Power: 1 watt
Mode: SP
Spot size: 
0.2mm
Sittings: Single
COLLOID MILIUM
AGE /  
SEX
SITE SETTINGS INTERVALS
42 Yrs / 
FM
FACE Power: 2W
Mode: CW
Spot Size: 2mm
Sittings: Two
6 Months
XANTHELASMA  PALPEBRARUM
Age / Sex Site Settings INTERVALS
30 / FM Upper Eyelid Power: 0.5 W
Mode: SP
Spot size: 
0.2mm
Sittings: Two
Three weeks
HYPERTROPHIC SCAR
AGE / SEX SITE SETTINGS INTERVALS
26Yrs / 
Female
Forehead Power:1
Mode: SP
Spot Size:0.2mm
Sittings:4
At an interval of 
about of 3 — 4 
weeks
KELOID
AGE / SEX SITE SETTINGS INTERVAL
S
30 – 50 yrs / 
Males
5 Patients
Chest Power: 8 –10 W
Mode: SP
Spot Size: 0.2mm
Sittings: 4
One Month
ACNE   KELOIDALIS  NUCHAE
AGE /  
SEX
SITE SETTINGS INTERVALS
18 Yrs / 
Male
Nape of 
the neck
Power:6W
Mode: CW
Spot size:1mm
Sittings: Two
Two weeks
ACTINIC CHEILITIS
AGE / SEX SITE SETTINGS INTERVALS
50 / Male Lower lip Power: 4 W
Mode: CW
Spot size: 2mm
Sittings: Single
RESULTS
ANGIOFIBROMA
Age /  
Sex
Site Settings 1ST 
WEEK
1ST MONTH 1ST YEAR
3 female 
patients;
15- 17yrs 
of age 
Face Power:4W
Mode: 
Continuous 
wave 
(CW)
Spot Size: 
2mm
No. of 
Sittings: 10
Ulcer 
in all 
the 
patients
Mild 
Postinflammatory 
Hyperpigmentation 
& Atrophy
Mild 
Postinflammatory 
Hyperpigmentation 
& Atrophy.
Psoriasis in one 
Patient
Relapse in one 
patient
2 Male 
Patients
20-30 yrs 
of age
Paranasal 
Area
Power:1W
Mode: 
Superpulse 
(SP)
Spot Size: 
0.2mm
No. of 
sittings:2
Ulcer No Atrophy & 
Pigmentation
INTRADERMAL NEVUS
Age / Sex Site Settings 1st week 1stmonth At the end of one year
1st Patient Right 
Cheek
Power:4W
Mode: CW
Spot size:2mm
No. of settings: 1
Ulcer Hyperpig
mented 
patcth. 
No 
atrophy
No pigmentation & 
atrophy
No relapse after one 
year
2nd 
Patient
Preauri
cular 
area
Power:4W
Mode: CW
Spot size:2mm
No. of settings:1
Ulcer Hyperpi
gmented 
patch. 
Mild 
atrophy
No pigmentation& 
Atrophy.
No Relapse after one 
year
3rd 
Patient
Tip of 
the 
Nose
Power:4W
Mode: CW
Spot size:2mm
No of settings:1
Ulcer Slight 
Hyperpi
gmentati
on & No 
Atrophy
No Pigmentation and 
Atrophy
No Relapse after 6 
months
NEVUS SEBACEOUS OF JADASSOHN
Age /  
Sex
Site Settings 1st Week 1Month 1Year
1st 
Patient
Lt. 
Cheek
Power:4W
Mode: 
CW
Spot Size: 
2mm
No. of 
Sittings:3
Ulceration, 
Erythema
Mild 
Hypopigmentation,Thikness 
of the plaque -- ↓ed
60% 
Dissappearance 
of lesion
No Relapse
2nd 
Patient
Verte
x
Power:1W
Mode: SP
Spot Size: 
0.2mm
No. Of 
Sittings:1
Ulcer
----------
Mild Scarring 
+
No Relapse
VERRUCOUS EPIDERMAL NEVUS
Age /  
Sex
Site Settings 1st 
Week
1st Month 6th Month
7 
patients 
5-20yrs 
of age
[4 
females,
3 
males]
Face, Nape 
of the 
Neck, 
Abdomen
Power: 
4-5W
Mode: CW
Spot 
Size:2mm
No. of 
Sittings:2-4
Ulcer Hypopigmentation
No Atrophy
Hypopigmentation
No atrophy
Relapse in one patient
Keloid in one Patient
7 
Patients
5-20yrs 
of age
[6 
males, 1 
female]
Face, 
Chest, 
Abdomen
Power: 
1-2W
Mode: SP
Spot 
Size:0.2mm
Sittings:2-4
Ulcer Hypopigmentation
Mild Atrophy
Hypopigmentation
Milia
Mild Atrophy
Three Relapsed at the 
periphery of the lesions
TATTOO REMOVAL
Age / Sex Site Settings 1 week 
Later
3 Month Later
23yr/ 
Male
Rt. Side of Chest Power:4 Watts
Mode: CW
Spot Size:2mm
Sitting: One
Ulcer with 
Crusting
Significant 
Reduction in 
Pigmentation
No atrophy
Age /  
Sex
Site Settings 1st Week 1 Month 
Later
4 months 
Later
26 
Yrs / 
Male
Lt. Side 
of Chest
Power:8 Watts
Mode: CW
Spot Size:2mm
Sittings:3
Ulcer, Mild 
Hypopigmentation
Mild 
Decrease in 
Pigmentation
No Atrophy
Moderate 
Decrease in 
Pigmentation
And Keloid 
NEVUS OF OTA
Age / Sex Site Settings 1 Month Later
28 Yrs / 
Male
Lt. Malar Area Power: 1
Mode: SP
Spot Size:0.2mm
Sitting: Single
Slight Dcrease in 
Pigmentation
LENTIGINES
Age /  
Sex
Site Settings 8th Month 1st Yr 16th Month
21 
Yrs / 
Female
FACE Power:1-2W
Mode: CW
Spot 
Size:1mm
Sittings:20
Mild reduction 
in pigmentation
Moderate 
Reduction in 
Pigmentation
Significant 
Reduction in 
Pigmentation
Age /  
Sex
Site Settings 1st Week End of 2nd 
month
25 Yrs / 
Male
FACE Power:0.5W
Mode: SP
Ulceration & 
Crusting
Almost complete 
disappearance of 
Spot 
Size:0.2mm
Sittings: One
lesions
Age / Sex Site Settings 40th Day 55th Day 3rd Month
28 Yr / 
Male
Rt.Temple
FACE
Power:2W
Mode: CW
Spot Size: 
2mm
Sittings:4
Power: 1W
Mode: CW
Spot 
Size:1mm
Sittings:4
Mild 
Reduction in 
size & 
Thickness
Mild 
Erythema
Mild 
Hypopigment
ation
No atrophy
50% 
reduction 
in size & 
Total 
Flattening
Mild 
Erythema 
& 
Hypopigm
entation
No 
Atrophy
75% reduction 
in Size
50 – 70% 
reduction in 
pigmentation
Mild 
Hypopigmentat
ion and 
erythema
No atrophy
LYMPHANGIOMA CIRCUMSCRIPTUM
Ag
e /  
Sex
Site Settings 15days Later 45 days Later 1st Yr 18 
Months 
Later
23 
yrs 
/ 
FM
Rt. Side 
of 
Abdomen
Power:8W
Mode: SP
Spot 
Size:0.2mm
Sittings:3
Ulcer Decrease in 
thickness
No 
Scarring or 
Pigmentary 
Changes
Relapse 
occured
Relapse
Occured.
Age /  
Sex
Site Settings 15 days Later 45 Days  Later
14 
yrs /
FM
Lt. Side of 
Chest
Power: 4W
Mode: CW
Size: 2mm
Sittings: Two
Mild erythema ,
hypopigmentation,
          and 
hyperpigmentation
90 % of lesions 
resolved.
Mild hyperpigmentation
ANGIOKERATOMA OF FORDYCE
Age /  
Sex
Site Settings 1st Week 2nd Week
46 Yrs / 
Male
Root of the 
Penis
Scrotum
For Both Sites
Power:1W
Mode: SP
Spot Size:0.2mm
Sittings: Single
Ulcer
Erythema
Penis: No 
Erythema / No 
Hypopigmentation
Scrotum: Mild 
Hypopigmentation
& Atrophy
MULTIPLE    TRICHOEPITHELIOMA
Age 
/  
Sex
Site Settings 2nd week 3rd Week 1st Month
30 
Yrs / 
Mal
e
Nose Power:2watts
Mode: SP
Spot 
Size:0.2mm
Sittings:4 
Ulceration
Crusting
Erythema
Erythema
Mild 
Redution in 
the size of 
Lesions
Erythema
Moderate 
Redution in the 
Size of the Lesions
SYRINGOMA
Age /  
Sex
Site Settings 2nd week 3rd  month 4th month
6 female 
patients,
20 - 30 
years
Upper 
eyelid
Power: 1 
watt
Mode: SP
Spot size: 
0.2mm
Sittings: 
Single
Mild 
hypopigmentation 
and erythema. 
Slight atrophy
Mild 
hypopigmenta
tion
No 
pigmentary 
changes
COLLOID MILIUM
Age /  
Sex
Site Settings 1st  Week 6 Months 
later
One Yr Later
42 
Yrs / 
FM
FACE Power: 2W
Mode: CW
Spot Size: 
2mm
Sittings: Two
Erythema
Erosions
25% 
Reduction in 
the number of 
lesions
50% Reduction in the 
number of lesions
Relapse present
No scarring  or 
Pigmentary  changes
XANTHELASMA  PALPEBRARUM
Age /  
Sex
Site Settings 3rd Week 2 Months later
30 / FM Upper 
Eyelid
Power: 0.5 
W
Complete 
flattening 
Almost complete 
disappearance of 
Mode: SP
Spot size: 
0.2mm
Sittings: 
Two
of lesions lesions
Mild 
hypopigmentation
HYPERTROPHIC SCAR
Age /  
Sex
S ite Settings 1st Week 45th Day 2nd Month
26Yrs 
/ 
Femal
e
Forehead Power:1
Mode: SP
Spot 
Size:0.2mm
Sittings:4
Erythema 
Hypopigmentation
No 
Erythema
Mild 
Reduction 
in 
Thickness 
of the 
Plaque
Moderate 
Reduction in 
Thickness
Erythema
Mild 
Hypopigmentation
KELOID
Age / Sex Site Settings 1st Month 2nd Month 3rd Month
30 – 50 yrs / 
Males
5 Patients
Chest Power: 8 –10 
W
Mode: SP
Spot Size: 
0.2mm
Mild 
reduction 
in size
No change 
in size
No change in 
size
Sittings: 4
ACNE   KELOIDALIS  NUCHAE
Age /  
Sex
Site Settings 1st Week 2nd Week One Month
18 Yrs / 
Male
Nape of the neck Power:6W
Mode: 
CW
Spot 
size:1mm
Sittings: 
Two
Erosions
Erythema
Erythema No reduction 
in size
ACTINIC CHEILITIS
Age / Sex Site Settings One month 
later
50 / Male Lower lip Power: 4 W
Mode: CW
Spot size: 2mm
Sittings: Single
Almost 
complete 
disappearance 
of  the lesion
                                            DISCUSSION
ANGIOFIBROMA:
 According to Bellack et al16 CO2 laser is the treatment of choice for patients with 
extensive facial angiofibromas. In a study done by Kaushal K.Verma et al16, four patients 
were treated with a power of 12-16 watts continuous defocused mode. At the end, all the 
patients had 50-80% improvement in their lesions. In another study by Papadavid et al17, 
reported 77% improvement in lesions with continuous defocused mode at a power of 
5-20 watts. In our study three female patients between 15 – 17 years of age and two male 
patients between 20 – 30 years of age with extensive angiofibromas were chosen. For 
both groups, the lesions are divided into different groups and each group of lesions were 
vaporized in single sitting. For the first group, the power used was 4 watts, continuous 
mode at a spot size of 2mm. Similarly, for the second group, the power used was one 
watts, superpulse at a spot size of 0.2mm. In the first group, patients developed mild 
postinflammatory hyperpigmentation and atrophy ( Fig.1, 2, 3, 4). One patient in this 
group  developed  psoriasis  vulgaris  during  the  course  of  therapy  as  a  koebner 
phenomenon ( Fig.5). About 75% disappearance of lesions occurred in this group. In the 
second group, no pigmentary changes or atrophy were observed ( Fig.6, 7, 8, 9, 10, 11). 
Perhaps better results would have been obtained with more treatment exposure and better 
patient compliance.
INTRADERMAL  NAEVUS:
In a study conducted by Lawrence Khoo18, 66 patients were treated with a 
power of 5-6 watts, superpulse mode. 86% achieved complete clearance, 14% had partial 
relapse and 6% relapsed totally. In our study three patients were treated for intradermal 
naevi with a power of four watts, continuous mode at a spot size of 2mm. All the patients 
were  followed  up  for  a  period  of  six  months  to  one  year.  They  developed 
hyperpigmentation by the end of one month and subsequently attained normal skin color( 
Fig.12,13,14,15,16). There was no relapse in all three patients ( Fig.14,16 ). Patients were 
very well satisfied with the results and they attained 100% improvement.
NAEVUS SEBACEOUS OF JADASSOHN:
In a study done by Kaushal K.Verma et al19, 4 patients were treated with 
10-20  watts  delivered  in  continuous  defocused  mode.  Three  patients  showed  90% 
improvement and one patient showed 60% improvement. In our study, both patients were 
treated with 4 watts continuous wave defocused mode at a spot size of 2mm. Both of 
them developed ulceration and erythema which healed by the end of second week. In the 
first patient, there was 60% disappearance of lesion by the end of one year ( Fig.17,18 ). 
The second patient showed complete disappearance of lesion with single sitting with a 
patch of hair loss with mild atrophy by the end of one year ( Fig.19,20 ). Both the patients 
showed no relapse. But recurrences on a long term follow-up and in a larger group of 
patients needs to be evaluated.
VERRUCOUS EPIDERMAL NEVI:
In a study done by Kaushal K.Verma et al19, 4 patients were treated with 
10-20%  watts  in  a  continuous  defocused  mode.  Three  patients  showed  80-90% 
improvement while one had poor (30%) response. In our study fourteen patients were 
taken and divided into two groups of seven each. First  group treated with   4-5 watts 
continuous wave mode at a spot size of about 2mm. Another group treated with 1-2 watts 
super  pulse  mode  at  a  spot  size  of  0.2mm.  In  the  first  group,  6  patients  developed 
hypopigmentation without atrophy ( Fig.21,22,23,24,25,26,27 ). Only one patient showed 
relapse by  the end of 3rd month(Fig.28).  In the second group, all the patients  developed 
hypopigmentation with mild atrphy ( Fig.29, 30 ).One patient developed keloid ( Fig.31 ) 
in the first group and another one developed milia like papules( Fig.32 )in the second 
group. Three patients relapsed at the periphery of the lesions. We had a follow up of six 
months only except one patient. Therefore, recurrences on a longterm follow-up and in a 
larger group of patients needs to be evaluated.
If  the  treatment  is  superficial,  with  only  the  epidermis  removed,  the  nevus 
regrows. If the treatment goes too deeply into the reticular dermis, a hypertrophic scar 
can  develop.  Therefore,  vaporization  or  coagulation  should  be  carried  out  into  the 
papillary  dermis.  This  procedure  seems  to  reduce  the  chance  of  recurrence  while 
minimizing the risk of scarring. The expected outcome after healing from this treatment 
is hypopigmentation.
TATTOO REMOVAL:
In a study conducted by Howard Levine and Philip Bailin27, 16 patients 
were treated with approximately 15-25 watts with a spot size of 2mm. In all but two 
cases, removal of the pigment was complete after  a single treatment. No true keloids 
developed and no hypertrophic scar formation persisted. In another study by Lanigan, 
Sheehan-Dare and Cotterill28, 51 patients were treated with 10-20watts with defocused 
beam of 3mm diameter. An excellent or good response was seen in 2/3 rd of patients 
reviewed with an 8.5% incidence of hypertrophic scarring. In our study, two patients 
were taken and one of them is treated with 4watts continuous mode at a spot size of 2mm 
and another one treated with 8watts continuous mode at a spot size of 2mm.In the first 
patient, there was 80% clearance of the lesion with two sittings without any atrophy and 
pigmentary  changes  (  Fig.33,  34  ).  The  second  patient  showed  50%  decrease  in 
pigmentation after three sittings with keloid formation ( Fig.36 ) after the third sitting but 
no atrophy ( Fig.35, 36 ).
NEVUS OF OTA: 
It is a dermal melanocytic hamartoma with the laser of choice being the Q-
Switched Ruby laser. In one study,  combination of CO2 laser and QSwitched Ruby laser 
was used29. But we have tried CO2 laser in one patient with a power of 1watt superpulse 
mode at  a  spot  size of  0.2mm.  There  was 25% reduction in  pigmentation  with mild 
erythema with single sitting ( Fig.37, 38 ). No hypopigmentation or atrophy were noted
LENTIGINES:
In a study done by Dover JS et.al30. 5 patients were treated with fluences of 3.0, 
3.7 or 4.4 J/ cm2. six weeks latwer, 9.9% of lesions cleared completely, 66.9% of lesions 
lightened substantially and 23.1% of lesions remained unchanged. In our study, 21 year 
old female patient with centrofacial lentiginosis treated with 1 - 2 watts continuous mode 
at a spot size of  1mm. There was 90% decrease in pigmentation after twenty sittings 
without scarring ( Fig.39, 40 ). Another two patients with facial lentiginosis were treated 
with 1-2 watts continuous wave mode at a spot size of 1mm. The first patient with lesions 
over the face showed almost complete disappearance of lesions on both sides of face with 
single sitting after two months ( Fig.41, 42, 43 ). In the second patient, the temple lesion 
showed 75% reduction in size as well  as  in pigmentation without atrophy after  four 
sittings ( Fig.44, 45, 46 ). The face lesions showed 50-70% reduction in pigmentation 
with mild hypopigmentation and erythema without atrophy after four sittings ( Fig.47, 48, 
49, 50 ). 
LYMPHANGIOMA CIRCUMSCRIPTUM
In a study done by Joyce lim32,  7 patients with lymphangioma circumscriptum 
were treated with CO2 laser. But the results were disappointing with either recurrences or 
scarring. In our study, two female patients were chosen and one of them was treated with 
8 watts superpulse mode at a spot size of 0.2mm and another one treated with 4 watts 
continuous mode at a spot size of 2mm. In the first patient, there was no improvement at 
all with relapse occurred 18 months later ( Fig.51, 52 ). The second patient showed 90% 
improvement in lesions with mild hyperpigmentation after two sittings ( Fig.53, 54 ) and 
should be followed up over a long period to watch out for any recurrences at the same 
site.
ANGIOKERATOMA OF FORDYCE
In a study done by Joyce Lim32, 9 patients with angiokeratoma of the vulva or 
scrotum were treated with the CO2 laser and the lesions cleared.  However it  did not 
prevent  recurrences.  In  our  study,  46  year  old  male  patient  was  treated  with  1watt 
superpulse mode at a spot size of 0.2mm. All the lesions are cleared without erythema 
and pigmentary changes over the penis and with mild hypopigmentation and atrophy over 
the scrotum ( Fig.55, 56 ). But the patients should be followed up over a long period to 
watch out for any recurrence at the same site.
MULTIPLE TRICHOEPITHELIOMA:
In a study done by A.L.Gerretsen and J.Toonstra37,  a  35 year old woman was 
treated  with  4-5  watts  continuous  defocused  mode.  The  cosmetic  result  was  very 
satisfactory with only minimal scarring after five separate sessions.  In our study, 30year 
old male patient was treated with 2watts superpulse mode at a spot size of 0.2mm. Patient 
showed erythema with moderate reduction in the number and size of the lesions after four 
sittings ( Fig.57, 58 ).  Perhaps better results would have been obtained with frequent 
treatment exposures and better patient compliance.
. SYRINGOMA
In a study done by Lawrence Khoo18,  90 patients  were treated with 5-6 watts 
superpulse mode. 76% of the patients were followed up for a mean of 6.9 months. 56% 
achieved complete  clearance,  40% had partial  relapse  and 4% relapsed  totally.  8.6% 
developed mild depressed scarring, 8.6% had transient post treatment hyperpigmentation 
and  4%  had  hypopigmentation.  In  our  study,  6  patients  were  treated  with  1watt 
superpulse mode at a spot size of 0.2mm. Three patients achieved complete clearance and 
three patients showed relapse after single sitting over a follow up period of 3-4 months 
( Fig.59, 60 ).
All  patients  developed  mild  hypopigmentation  with  slight  atrophy.  But  the  patients 
should be followed up over a long period to watch out for any recurrences
COLLOID MILIUM
In a study done by Kullavani Jaya P42, CO2 laser was used in the treatment of 
topical hydroquinone induced colloid milium. The CO2 laser treatments were performed 
with good results. In our study, 42 year old female patient with lesions over the face was 
treated with 2 watts continuous mode at a spot size of 2mm at an interval of 6 months. 
There was 25% reduction in the number of lesions with single sitting. Subsequently there 
was  50%  reduction  in  the  number  of  lesions  after  two  sittings  without  atrophy  or 
pigmentary changes      ( Fig.61, 62 ). The patient showed relapse after eight months 
( Fig.62 ).
XANTHELASMA PALPEBRARUM:
In a study done by Yehuda Ullman, Yaron Harshai and Isaac J.Peled43, 22 
patients were selected and treated with 3-5 watts ( depending on the thickness of the 
plaque)  continuous mode at  a  spot  size  of  1mm. Out  of  22 patients,  only 4 patients 
required two sessions and the other patients  were treated in one session.  59% 0f the 
patients  showed  excellent  results  and  41%  of  the  patients  showed  good  response. 
Recurrence  rate  was  found  to  be  9%.  Pigmentary  changes  were  noted  as  follows: 
hypopigmentation(18%); hyperpigmentation (5%). No eyelid retraction. In our study, a 
30 year old normolipemic female patient was treated with 0.5watt superpulse at a spot 
size of 0.1mm. There was complete flattening of lesions by third week after first sitting 
(  Fig.63,64  ).  There  was  almost  complete  disappearance  of  the  lesion  with  mild 
hypopigmentation after two sittings ( Fig.65 ). No atrophy was noted.
HYPERTROPHIC SCAR:
In a study done by Alster TS, Lewis AB and Rosenbach A48, twenty patients with 
nonerythematous  hypertrophic  scar  were  treated  with  high-energy,  pulsed  co2  laser. 
Global assessment scores and erythema spectrometry measurements were significantly 
improved after treatment. 
In  our  study,   one  patient  with  scar  on  the  forehead  was  treated  with  1watt 
superpulse mode at a spot size of 0.2mm. There was 75% reduction in the thickness of 
the  scar  with  mild  erythema  and  hypopigmentation  (  Fig.66,  67  ).  The  pigmentary 
changes will resolve over a period of time.
KELOID
In a study done by Kantor GR et al50, there were 17 recurrences in a group of 23 
keloids excised by laser. In another study by Apfelberg DB et al51,  seven patients with 
keloids have been treated by excision with the CO2 laser. Eight of the the nine keloids 
have recurred to their original or close the original site. Only one patient has greatly 
improved after only 9 months follow up. The long term benefits of keloid excision with 
the CO2 laser is not demonstrated in this case study series. In another study by Lawrence 
Khoo18, 9 patients were treated for keloids. The keloids would be debulked using either 
continuous or superpulse mode with an average power of 6-8 watts. This would then be 
followed by ablation of the remaining keloid. 89% of the patients were followed up for a 
mean  of  7.6  months.22% achieved  complete  clearance,  75% had  partial  relapse.  No 
complication was noted after treatment.  In a review article by Mutalik sharad52,, ample 
reports have demonstrated the use of CO2 laser for ablating the keloid lesions, but similar 
to the excision modality, the failure rate is 100% as the laser ablation actually burns the 
lesions.
In our study, five patients were treated with  8 - 10watts superpulse mode at a spot 
size of 0.2mm. There was recurrence even after five sittings in all patients ( Fig.68, 69 ).
ACNE KELOIDALIS NUCHAE
In a study done by Kantor GR et al55, CO2 laser was used in the treatment of 
refractory acne keloidalis  nuchae with good results.  In our study,  a male patient was 
treated with 6 watts continuous mode at a spot size of 1mm. There was no improvement 
at all with relapse occurred after 2 sittings ( Fig.70,71 ).
ACTINIC CHEILITIS
In a study done by George J.Hruza56, actinic cheilitis was treated with 3-7 watts 
continuous  mode  and  healing  takes  place  upto  4  weeks  with  excellent  response.  In 
another study by Dufresne RJ Jr et al57, 13 patients were treated with both conventional 
and superpulsed modes. The procedure was well tolerated. Focal, but not functionally 
restricting,  scarring  developed  in  three  patients.  The  cosmetic  result  was  otherwise 
excellent. No recurrences have been noted. In our study, 50 year old male patient was 
treated with 4 watts continuous mode at a spot size of 2mm. One month later, there was 
90% clearance of the lesions with single sitting ( Fig. 72, 73 ).
 CONCLUSION
1.  In  our  study,  CO2 laser  gave  excellent  results  in  conditions  like  Actinic  cheilitis, 
Intradermal  nevus,  Verrucous  epidermal  nevus,  Xanthelasma  palpebrarum  and 
Syringoma.
2. In our study, CO2 laser gave good results in conditions like Angiofibroma, Tattoo 
removal, Hypertrophic scar and Angiokeratoma of Fordyce.
3. In conditions like, Multiple Trichoepithelioma, Nevus of Ota and Colloid milium, there 
was only minimal improvement. Perhaps better results would have been obtained with 
more treatment exposures and better patient compliance.
4.  In  conditions  like,  Keloid,  Acne  keloidalis  nuchae  and  Lymphangioma 
circumscriptum, there was high incidence of recurrences even after adequate treatment 
sessions.
5. The conditions included in our study should be followed up over a long period to 
watch out for any recurrences following CO2 laser treatment.
6. The side effects like hypopigmentation, hyperpigmentation and mild atrophy would 
resolve over a period of time.
7.  Keloidal  scars  were  developed  in  two cases  following  the  treatment  of  verrucous 
epidermal nevus and tattoo removal which may be due to the inherent tendency of the 
patients.
8.  CO2  laser  offers  a  well  tolerated  treatment  modality  without  compromising  the 
cosmetic aspects.
9. The CO2 laser is a good method of treatment for various benign skin lesions, 
especially where precise tissue ablation and concomitant haemostasis are desired.
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